US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist

25.3500
+0.8900+3.64%

Close Jan 10 16:00 ET

25.5700
+0.2200+0.87%

Post 18:38 ET

154.04MMarket Cap-12.80P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monopar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Monopar Therapeutics Earnings Reports

Monopar Therapeutics | 8-K: Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

Nov 8, 2024 08:05 ET

Monopar Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 08:05 ET

Monopar Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9, 2024 08:07 ET

Monopar Therapeutics | 8-K: Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments

Aug 9, 2024 08:02 ET

Analyst Rating

Updated: Jan 11, 2025

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall